Abstract:Bone infection results in a complex inflammatory response and bone destruction. A broad spectrum of bacterial species has been involved for jaw osteomyelitis, hematogenous osteomyelitis, vertebral osteomyelitis or diabetes mellitus, such as Staphylococcus aureus (S. aureus), coagulase-negative Staphylococcus species, and aerobic gram-negative bacilli. S. aureus is the major pathogenic bacterium for osteomyelitis, which results in a complex inflammatory response and bone destruction. Although various antibiotics have been applied for bone infection, the emergence of drug resistance and biofilm formation significantly decrease the effectiveness of those agents. In combination with gram-positive aerobes, gram-negative aerobes and anaerobes functionally equivalent pathogroups interact synergistically, developing as pathogenic biofilms and causing recurrent infections. The adhesion of biofilms to bone promotes bone destruction and protects bacteria from antimicrobial agent stress and host immune system infiltration. Moreover, bone is characterized by low permeability and reduced blood flow, further hindering the therapeutic effect for bone infections. To minimize systemic toxicity and enhance antibacterial effectiveness, therapeutic strategies targeting on biofilm and bone infection can serve as a promising modality. Herein, we focus on biofilm and bone infection eradication with targeting therapeutic strategies. We summarize recent targeting moieties on biofilm and bone infection with peptide-, nucleic acid-, bacteriophage-, CaP- and turnover homeostasis-based strategies. The antibacterial and antibiofilm mechanisms of those therapeutic strategies include increasing antibacterial agents’ accumulation by bone specific affinity, specific recognition of phage-bacteria, inhibition biofilm formation in transcription level. As chronic inflammation induced by infection can trigger osteoclast activation and inhibit osteoblast functioning, we additionally expand the potential applications of turnover homeostasis-based therapeutic strategies on biofilm or infection related immunity homeostasis for host-bacteria. Based on this review, we expect to provide useful insights of targeting therapeutic efficacy for biofilm and bone infection eradication.

Research progress in molecular mechanism of bone homeostasis imbalance due to bone infection

Research progress on osteoclasts to promote bone remodeling

[Research Progress on the Regulatory Cell Death of Osteoblasts in Periodontitis].

Mechanisms of Promoting the Differentiation and Bone Resorption Function of Osteoclasts by Staphylococcus Aureus Infection

Research progress of stimulus-responsive antibacterial materials for bone infection

Advances in mechanism and management of bone homeostasis in osteonecrosis: a review article from basic to clinical applications

New Perspectives on Traumatic Bone Infections

Mini Review Therapeutic Strategies Targeting for Biofilm and Bone Infections

Bone immunity and bone metabolism

Prospects and challenges for the application of tissue engineering technologies in the treatment of bone infections

Research progress on gut microbiota regulating bone metabolism

Research progress in molecular coupling mechanism of osteogenic differentiation and angiogenesis in traumatic bone defects

Progress in diagnosis and treatment of fracture-related infection

Advances in Pathogenesis and Therapeutic Strategies for Osteoporosis

Antibacterial Biomaterials in Bone Tissue Engineering

Implantable biomedical materials for treatment of bone infection

[Research progress of the effect of "gut-immune" axis on bone homeostasis]

Research Progress of the Molecular Signal Pathway in the Prevention and Treatment of Osteoporosis

Research Progress on the Interactions between Bone Cells and Immune Cells

Bacterial biofilm and chronic osteomyelitis

Bone Homeostasis and Gut Microbial-Dependent Signaling Pathways